Claudia has 20 years of experience and a proven record of accomplishment in corporate development, investor relations and communications. She started her career in corporate finance at WestLB AG in Germany, where she managed mergers and acquisition (M&A) projects across various industries. Following the completion of her MBA at Instituto de Empresa in 2005, she joined the biotechnology company TiGenix, taking responsibility for corporate development and leading the company’s partnering efforts that culminated in a deal with Takeda worth up to €380M. Following the company’s Nasdaq IPO, Claudia became responsible for investor relations and corporate communications until the completion of the acquisition of TiGenix by Takeda in 2018.
Jose is a specialist in viral infectious diseases and in the development of biotechnology applications of viruses, with more than 120 scientific contributions in international journals and numerous licensed patents. He is on the editorial board of several virology and biotechnology journals. José is a graduate and Ph.D from Complutense University of Madrid in Veterinary Medicine and carried out postdoctoral studies in different institutions of USA. Jose served as Research Professor in a Spanish scientific institution and has over 25 years of experience in science management. As entrepreneur, he is co-founder of ALGENEX and LogicBiology.
Romy has more than 17 years of experience on Molecular Biology and Virology and eleven scientific publications in peer reviewed journals. She has worked first as a researcher and then as a Project Leader at several Biotech Companies. She joined ALGENEX more than three years ago in the position of Chief Operations Officer and manages the Comercial Agreements, Human Resources, Patent Portfolio and supervises the scientific projects.
Virginia has 20 years experience in different financial positions. After completing her degree in Business Administration at the University of Oviedo, Spain, she joined the finance department of Decathlon. During this period she completed a master in Business Administration. She later joined the biotechnology company TiGenix, a dual listed Company (Nasdaq & Euronext ) recently acquired by Takeda, in which held different roles of responsibility such as finance director and head of controlling and consolidation for more than 13 years. During this period she also completed an Advance Management Program at Instituto de Empresa, Madrid.